Skip to main content
Erschienen in: Tumor Biology 5/2013

01.10.2013 | Research Article

Comprehensive assessment of the association between DNA repair gene XRCC3 rs861539 C/T polymorphism and lung cancer risk

verfasst von: Gang Ding, Weiguo Xu, Hongwei Hua, Qian Huang, Hongxiang Liang, Yufeng Ni, Zhaoheng Ding

Erschienen in: Tumor Biology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

A few case–control studies were performed to assess the association between X-ray repair cross-complementing group 3 (XRCC3) rs861539 C/T polymorphism and lung cancer susceptibility, but no consistent finding was reported. In the present study, we performed a meta-analysis of 14 case–control studies with a total of 7,869 lung cancer cases and 10,778 controls to provide a comprehensive assessment of the association between XRCC3 rs861539 C/T polymorphism and lung cancer risk. Pooled odds ratios (ORs) and corresponding 95 % confidence intervals (95 % CIs) were calculated to assess the strength of the association. Overall, there was no significant association between XRCC3 rs861539 C/T polymorphism and lung cancer risk under all genetic models [OR (95 % CI) for T versus C, 1.00 (0.89–1.13), P = 0.99; OR (95 % CI) for TT versus CC, 1.07 (0.81–1.41), P = 0.62; OR (95 % CI) for TT/CT versus CC, 0.95 (0.84–1.07), P = 0.39; OR (95 % CI) for TT versus CT/CC, 1.10 (0.86–1.39), P = 0.62]. In the subgroup analyses of both Asians and Caucasians, there was still no significant association between XRCC3 rs861539 C/T polymorphism and lung cancer risk under all genetic models (All P values were more than 0.05). However, there was an obvious association between XRCC3 rs861539 C/T polymorphism and decreased risk of lung cancer in the subgroup analysis of the mixed population (All P values were less than 0.05). In addition, there was some risk of publication bias in the meta-analysis, and there was obvious discrepancy in the findings between studies with large sample size and studies with small sample size in the meta-analysis. The meta-analysis indicates that the association between XRCC3 rs861539 C/T polymorphism and lung cancer risk is still uncertain owing to the obvious discrepancy in the findings between studies with large sample size and studies with small sample size. More studies with large sample size are needed to further assess the association.
Literatur
2.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
3.
Zurück zum Zitat Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, et al. Non-small-cell lung cancer. Lancet. 2011;378:1727–40.CrossRefPubMed Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, et al. Non-small-cell lung cancer. Lancet. 2011;378:1727–40.CrossRefPubMed
4.
Zurück zum Zitat Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299:2423–36.PubMedCentralCrossRefPubMed Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299:2423–36.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Chen X, Liang L, Hu X, Chen Y. Glutathione s-transferase p1 gene ile105val polymorphism might be associated with lung cancer risk in the Chinese Han population. Tumour Biol. 2012;33:1973–81.CrossRefPubMed Chen X, Liang L, Hu X, Chen Y. Glutathione s-transferase p1 gene ile105val polymorphism might be associated with lung cancer risk in the Chinese Han population. Tumour Biol. 2012;33:1973–81.CrossRefPubMed
6.
Zurück zum Zitat Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol. 2011;12:399–408.CrossRefPubMed Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol. 2011;12:399–408.CrossRefPubMed
7.
Zurück zum Zitat Hayden PJ, Tewari P, Morris DW, Staines A, Crowley D, Nieters A, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum Mol Genet. 2007;16:3117–27.CrossRefPubMed Hayden PJ, Tewari P, Morris DW, Staines A, Crowley D, Nieters A, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum Mol Genet. 2007;16:3117–27.CrossRefPubMed
8.
Zurück zum Zitat Otsuki M, Seki M, Inoue E, Yoshimura A, Kato G, Yamanouchi S, et al. Functional interactions between BLM and XRCC3 in the cell. J Cell Biol. 2007;179:53–63.PubMedCentralCrossRefPubMed Otsuki M, Seki M, Inoue E, Yoshimura A, Kato G, Yamanouchi S, et al. Functional interactions between BLM and XRCC3 in the cell. J Cell Biol. 2007;179:53–63.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Leng S, Stidley CA, Willink R, Bernauer A, Do K, Picchi MA, et al. Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res. 2008;68:3049–56.PubMedCentralCrossRefPubMed Leng S, Stidley CA, Willink R, Bernauer A, Do K, Picchi MA, et al. Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res. 2008;68:3049–56.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Zhu X, Zhong Z, Zhang X, Zhao X, Xu R, Ren W, et al. DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese population. Genet Test Mol Biomarkers. 2012;16:640–3.CrossRefPubMed Zhu X, Zhong Z, Zhang X, Zhao X, Xu R, Ren W, et al. DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese population. Genet Test Mol Biomarkers. 2012;16:640–3.CrossRefPubMed
11.
Zurück zum Zitat David-Beabes GL, Lunn RM, London SJ. No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:911–2.PubMed David-Beabes GL, Lunn RM, London SJ. No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:911–2.PubMed
12.
Zurück zum Zitat Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003;191:171–8.CrossRefPubMed Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003;191:171–8.CrossRefPubMed
13.
Zurück zum Zitat Harms C, Salama SA, Sierra-Torres CH, Cajas-Salazar N, Au WW. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen. 2004;44:74–82.CrossRefPubMed Harms C, Salama SA, Sierra-Torres CH, Cajas-Salazar N, Au WW. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen. 2004;44:74–82.CrossRefPubMed
14.
Zurück zum Zitat Jacobsen NR, Raaschou-Nielsen O, Nexo B, Wallin H, Overvad K, Tjonneland A, et al. XRCC3 polymorphisms and risk of lung cancer. Cancer Lett. 2004;213:67–72.CrossRefPubMed Jacobsen NR, Raaschou-Nielsen O, Nexo B, Wallin H, Overvad K, Tjonneland A, et al. XRCC3 polymorphisms and risk of lung cancer. Cancer Lett. 2004;213:67–72.CrossRefPubMed
15.
Zurück zum Zitat Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25:2433–41.CrossRefPubMed Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25:2433–41.CrossRefPubMed
16.
Zurück zum Zitat Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. 2006;27:997–1007.CrossRefPubMed Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. 2006;27:997–1007.CrossRefPubMed
17.
Zurück zum Zitat Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006;27:560–7.CrossRefPubMed Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006;27:560–7.CrossRefPubMed
18.
Zurück zum Zitat Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain. BMC Cancer. 2007;7:162.CrossRefPubMed Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain. BMC Cancer. 2007;7:162.CrossRefPubMed
19.
Zurück zum Zitat Zhang ZL, Zhou CC, Zhang J, Tang L, Su B. Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30:936–40.PubMed Zhang ZL, Zhou CC, Zhang J, Tang L, Su B. Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30:936–40.PubMed
20.
Zurück zum Zitat Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008;17:3081–9.PubMedCentralCrossRefPubMed Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008;17:3081–9.PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
23.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMed
25.
Zurück zum Zitat Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, et al. Polymorphisms of the DNA repair genes xrcc1 and xrcc3 and risk of lung and colorectal cancer: a case–control study in a southern Italian population. Anticancer Res. 2008;28:2941–6.PubMed Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, et al. Polymorphisms of the DNA repair genes xrcc1 and xrcc3 and risk of lung and colorectal cancer: a case–control study in a southern Italian population. Anticancer Res. 2008;28:2941–6.PubMed
26.
Zurück zum Zitat Huang M, Chen X, Qiu Y, Fan L, Chen J, L C. Relationship between XRCC3 gene polymorphisms and lung cancer. Wei Sheng Yan Jiu. 2011;40:187–90.PubMed Huang M, Chen X, Qiu Y, Fan L, Chen J, L C. Relationship between XRCC3 gene polymorphisms and lung cancer. Wei Sheng Yan Jiu. 2011;40:187–90.PubMed
27.
Zurück zum Zitat Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.CrossRefPubMed Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.CrossRefPubMed
28.
Zurück zum Zitat Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7:954–62.CrossRefPubMed Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7:954–62.CrossRefPubMed
29.
Zurück zum Zitat Yin M, Liao Z, Huang YJ, Liu Z, Yuan X, Gomez D, et al. Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS One. 2011;6:e20055.PubMedCentralCrossRefPubMed Yin M, Liao Z, Huang YJ, Liu Z, Yuan X, Gomez D, et al. Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS One. 2011;6:e20055.PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Xiao XY, Wang XD, Zang DY. Mmp1-1607 1g/2g polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2012;33:2385–92.CrossRefPubMed Xiao XY, Wang XD, Zang DY. Mmp1-1607 1g/2g polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2012;33:2385–92.CrossRefPubMed
Metadaten
Titel
Comprehensive assessment of the association between DNA repair gene XRCC3 rs861539 C/T polymorphism and lung cancer risk
verfasst von
Gang Ding
Weiguo Xu
Hongwei Hua
Qian Huang
Hongxiang Liang
Yufeng Ni
Zhaoheng Ding
Publikationsdatum
01.10.2013
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 5/2013
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0705-3

Weitere Artikel der Ausgabe 5/2013

Tumor Biology 5/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.